Health Care AI Still in Need of Breakthroughs (AI Translation)
Listen to the full version

文|财新周刊 陈曦 蒋模婷 崔笑天
By Caixin Weekly’s Chen Xi, Jiang Moding, Cui Xiaotian
患者拿起手机,讲述自己有何不适,提供病史信息,AI(人工智能)即刻可以提供包括“该挂什么科室”在内的就诊建议;另一边,这些内容又被自动整理成符合病历书写要求的语言,发送给即将接诊的医生——从看病的第一步起,患者如今可能越来越多地与AI产生交集。
Patients pick up their phones, describe their symptoms, provide medical history information, and instantly, artificial intelligence (AI) can offer healthcare advice, including which department to visit. Meanwhile, this information is automatically organized into language that meets medical record writing standards and sent to the doctor who will see them next. From the very first step of seeing a doctor, patients are increasingly likely to interact with AI.
2024年12月14日,《中国卒中学会急性缺血性卒中再灌注治疗指南2024》发布,其中提到在AI辅助下,急性卒中溶栓时间窗可以从4.5小时延长到24小时。被写入临床指南,折射出AI在医疗领域的潜力和价值。
On December 14, 2024, the "2024 Guidelines for the Reperfusion Therapy of Acute Ischemic Stroke" by the Chinese Stroke Association were released. The guidelines indicate that with the assistance of AI, the thrombolytic treatment window for acute stroke can be extended from 4.5 hours to 24 hours. This inclusion in clinical guidelines reflects the potential and value of AI in the medical field.
GPT掀起的大模型浪潮下,“AI+医疗”的热度再一次被点燃。2024年被业界称为“AI应用元年”,多位受访的产业界人士、医生和行业观察者都对财新提到,医疗和AI结合的时代正不可阻挡地到来。
In the wave of large models initiated by GPT, the enthusiasm for "AI+Healthcare" has once again been ignited. The year 2024 is being referred to by the industry as the "first year of AI application." Numerous industry professionals, doctors, and observers have mentioned to Caixin that the era of combining healthcare and AI is inevitably arriving.
- DIGEST HUB
- Medical AI can extend the treatment window for acute stroke from 4.5 to 24 hours and enhance healthcare efficiency, but its practical implementation faces challenges.
- Large-model AI is in its initial stages in healthcare, with regulatory, data, and payment system barriers affecting its growth and adoption.
- Hospitals are currently the primary payers for AI, with consumer applications emerging slowly, amidst calls for clearer top-level policies to support medical AI advancement.
[para. 1] Patients are increasingly interacting with AI from the first step of medical consultations, where AI processes their input for symptoms and medical history to provide healthcare advice and organize information for doctors according to medical record standards. [para. 2] A major milestone in AI healthcare integration is the extension of the thrombolytic treatment window for acute ischemic stroke from 4.5 to 24 hours, as reflected in the Chinese Stroke Association's guidelines, highlighting AI's transformative potential. [para. 3] The year 2024 is being called the "first year of AI application," emphasizing the rising integration of AI in healthcare, driven by large models and sparked by the advent of technologies like GPT.
[para. 4] AI promises to enhance healthcare by offering affordable patient "companions" to reduce hospital visits and queues. It can act as an intelligent assistant for diagnostics and surgery planning in hospitals, thereby improving efficiency in resource allocation. [para. 4][para. 5] AI also has vast potential in disease screening, epidemic monitoring, and hospital management. The key expectation from AI in healthcare is to alleviate the pressure between limited medical resources and increased healthcare demand. [para. 6] AI tools can expand the reach and efficiency of doctors, freeing time for complex cases or patients needing emotional support.
[para. 7] Prominent medical institutions are increasingly adopting AI, focusing on integrating it into clinical needs to enhance efficiency and patient experience. The future of medical AI hinges on proving its utility to both patients and medical institutions. [para. 8] Evidence shows that AI interactions, while introducing enhancements, need more refinement, as highlighted by patient experiences like that of Luo Ni, where repeated and mechanized responses dulled the AI's performance. [para. 9] Medical imaging departments often use AI products from different manufacturers, each excelling in different specific disease areas, representing the fragmented state of the industry.
[para. 10] While large-scale AI in healthcare is still immature, it faces significant restrictions due to its intricate applicability in life-centric domains. These challenges emphasize the need for medical AI to be developed with precision and seriousness. [para. 12] The medical AI industry is heavily influenced by policy and the market, particularly regarding who will bear the financial burden of these technologies. [para. 13] The future of AI hinges on clear regulatory frameworks designed to streamline its integration into healthcare systems, focusing on payment strategy and product evaluation.
[para. 14] Hospital procurement practices often integrate AI with hardware devices due to insufficient budgets. Industry professionals suggest hospitals are constrained by financial limits despite potential AI benefits. [para. 15] Experts advocate for a regulatory framework that comprehensively evaluates AI’s impact on healthcare costs, opening avenues for AI integration. [para. 16] The ultimate goal of AI is to navigate the challenges within healthcare systems, emphasizing the pressing need for a synthesis between technology, policy, and humane aspects.
[para. 17][para. 18] The current medical AI landscape is competitive, with public and private sectors contributing differently. Regulatory guides divide AI's applications into management, public health services, industry development, and education, reflecting a segmented approach to integrating AI in healthcare. [para. 19] While general medical AI systems remain underdeveloped, more targeted and specialized AI programs are gaining traction. Stakeholders across various sectors are diversifying their AI deployments. [para. 21] Traditional and tech giants are heavily investing in AI, recognizing its necessity in modern systems, yet face distinct challenges such as cultural adaptation and rapid technological changes.
[para. 22] Historical context shows that medical AI exploration began decades ago. However, past cycles of enthusiasm, marked by setbacks, warn the industry of potential pitfalls of rapid advancement. [para. 23][para. 24] Recent history indicates shifts in investment dynamics, with the medical AI field experiencing high valuation but facing challenges due to reduced investor confidence. Successful AI ventures must align technological and economic value propositions. [para. 27] Overall, rational approaches, inclusive of diverse collaborations and strategic frameworks, underpin the unfolding scenarios in the medical AI scene.
- CLOBOTICS
科洛华 - The article does not mention CLOBOTICS. It focuses on the integration of AI in healthcare, discussing the potential and challenges of AI applications across various medical fields, and the evolving landscape and expectations for AI in healthcare in China and globally.
- United Imaging Intelligence
联影智能 - United Imaging Intelligence is actively developing AI solutions for the healthcare sector. They emphasize a collaborative "med-engineering" approach, working closely with medical professionals. Their AI systems, like the DR lower limb line analysis, significantly enhance efficiency, reducing tasks from 15 minutes to seconds. County-level hospitals show notable demand for their AI products, with AI adoption leading to substantial increases in diagnostic efficiency and check-up volume, showcasing tangible value creation for healthcare facilities.
- ALSOLIFE
ALSOLIFE - ALSOLIFE focuses on autism spectrum children's assessment and intervention, significantly reducing treatment burdens with AI support. The company sees significant "C-end" potential in this sector due to high costs and non-standardized services. Zhang Zhiguang, ALSOLIFE's CEO, anticipates transformative industry changes with the advent of real-time voice interaction and digital human technologies, which could address existing challenges in the field.
- Rich Healthcare
瑞慈 - Rich Healthcare is mentioned as a high-end medical examination center where United Imaging's AI products, such as those for brain small vessel disease analysis, have been implemented. These AI products assist in exploring health management services, providing high-value-added services for specialized disease groups like cancer and cardiovascular conditions. Patients with these needs might be willing to pay extra, allowing AI companies to share in some of the revenue from these services.
- Viz.ai
Viz.ai - Viz.ai is a company known for developing clinical decision support AI. In 2020, its AI product became the first to be included in the U.S. Medicare directory, marking a significant milestone in the recognition and integration of AI in healthcare payment systems. This inclusion indicates the company's leadership in advancing AI applications in clinical settings and facilitating its broader acceptance within healthcare systems.
- Microsoft
微软 - Microsoft is highlighted as a key player in the AI revolution impacting healthcare. The company's global senior vice president, Peter Lee, authored a book describing the potential of GPT-4 in medical scenarios, demonstrating the system's capabilities. Microsoft, alongside other tech giants like Google, emphasizes AI's prospects in healthcare, showcasing their involvement in driving AI applications in the medical field.
- Google
谷歌 - The article mentions Google as part of the overseas tech giants, alongside Microsoft and OpenAI, emphasizing AI's potential in the medical field. However, it doesn't provide specific details on Google's individual initiatives or projects within the healthcare AI sector. The context suggests that Google, like other major tech companies, is exploring AI applications in healthcare, but the article doesn't delve into particular examples or outcomes related to Google's efforts.
- Tencent
腾讯 - The article mentions that Tencent has developed the "混元大模型" as part of their AI initiatives in the healthcare sector. This model is one of the various AI applications being deployed for medical use, focusing on areas such as consultations and diagnostics, alongside similar initiatives by other major tech companies in China.
- Baidu
百度 - Baidu has released "Lingyi" as its medical AI model, focusing on consultation as an application scenario during the AI boom led by GPT models. Alongside other tech giants like Tencent and Alibaba, Baidu emphasizes AI's potential in healthcare, aiming to innovate through its capabilities in medical queries and potentially impacting the field significantly.
- Alibaba
阿里 - Alibaba has developed a medical AI model called Tongyi Renxin, aiming to enhance healthcare through AI applications. This aligns with the broader trend of tech companies entering the medical AI space, alongside others like Tencent and Baidu. These initiatives reflect the push to integrate AI in healthcare, focusing on applications like diagnosis, personalized medicine, and patient management, contributing to the "AI+Healthcare" movement in China.
- JD.com
京东 - JD.com has released a large language model called Jingyi Qianxun, which focuses on medical applications alongside other tech giants like Tencent, Baidu, and Alibaba in China.
- ByteDance
字节 - ByteDance is mentioned as one of the diverse tech companies dabbling in medical AI applications. While not specifying detailed actions, the company is listed alongside others like Tencent and Baidu, suggesting involvement either through releasing specialized products or establishing business units related to healthcare AI.
- iFLYTEK
讯飞 - The article mentions iFLYTEK as one of the technology companies involved in AI applications in the medical field in China. It is listed alongside other companies such as ByteDance, SenseTime, and others that have explored or released AI products related to healthcare, indicating iFLYTEK's participation in this evolving industry.
- SenseTime
商汤 - The article mentions SenseTime as a tech company that has engaged in applying AI products within the healthcare sector. However, it doesn't provide detailed specifics about their contributions or products.
- Zhipu AI
智谱 - Zhipu AI is mentioned as a tech company with diverse backgrounds that is involved in AI applications in the medical field. They are known to have either specialized products released or a dedicated business segment focused on healthcare.
- GE
通用 - The article mentions GE (General Electric) as one of the traditional medical device companies actively incorporating AI technology into their large equipment as a widespread strategy. They, along with other major players like Philips, Siemens, and domestic leaders like United Imaging, are integrating AI solutions across their product lines to enhance healthcare services and technology offerings.
- Philips
飞利浦 - Philips, known as a traditional medical device company, is actively embracing AI. Alongside other giants like GE and Siemens, Philips is incorporating AI technologies and solutions into their large equipment as a widespread strategy. This move aligns with the company’s efforts to harness AI's potential in improving healthcare services and operations.
- Siemens
西门子 - In the article, Siemens, a traditional medical device company, is mentioned for its involvement in the AI field. It is noted as a medical imaging giant that is actively integrating AI technology and solutions into its large-scale equipment. This reflects a broader strategy among industry leaders to embrace AI in healthcare, similar to other companies like GE, Philips, and local Chinese leaders such as United Imaging, aiming to enhance their product offerings.
- United Imaging
联影 - United Imaging is actively involved in the medical AI ecosystem. The company has developed AI-powered products like its DR lower limb alignment analysis system, which significantly improves diagnostic efficiency in hospitals. United Imaging emphasizes "medic-engineering" collaboration within real medical scenarios, working closely with doctors to ensure AI products meet clinical needs and improve healthcare quality. The company has noted increased demand for AI products from county hospitals, driven by their potential to enhance hospital capabilities.
- Mindray
迈瑞 - The article mentions Mindray as a domestic leader in the medical equipment sector that is actively integrating AI technology and solutions into large-scale equipment. This approach is positioned as a common strategy among medical device companies like Mindray, GE, and Siemens, to harness AI technology in their offerings.
- Neusoft
东软 - The article mentions Neusoft as one of the domestic leaders in medical imaging, alongside others like GE, Philips, Siemens, United Imaging, and Mindray. These companies are noted for their integration of AI technology and solutions into large-scale equipment, which is a standard strategy in the industry.
- After 2020:
- Medical imaging AI received approval for 'Class III' medical device certificates.
- 2021:
- Total funding for medical AI amounted to 11.5 billion yuan, but decreased shortly after.
- August 2021:
- Yitu Technology sold its subsidiary Yitu Healthcare to Shenyuan Medical.
- By 2023:
- Total funding for medical AI decreased to 2.96 billion yuan.
- July 2024:
- Luo Ni experienced an AI pre-consultation for mole removal during an online appointment.
- November 6, 2024:
- National Health Commission and other bodies released the 'Reference Guide for Application Scenarios of Artificial Intelligence in the Health Industry.'
- November 20, 2024:
- The National Healthcare Security Administration released the 'Guidelines for Pricing Medical Services in Radiological Examinations (Trial),' including 'AI-assisted diagnosis' as an extension item.
- December 14, 2024:
- The '2024 Guidelines for the Reperfusion Therapy of Acute Ischemic Stroke' by the Chinese Stroke Association were released.
- MOST POPULAR



